After a $56.3M sale, Twist Bioscience (TWST) officer Leproust proposes another share sale.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Emily M. Leproust, an officer and director at Twist Bioscience (TWST), has proposed selling 4,548 common shares valued at $919,373.72, with an approximate sale date of October 5, 2026. This proposed sale follows a significant prior sale on September 17, 2026, where Leproust sold 356,546 shares for over $56.3 million. The article details the proposed transaction and provides context on previous insider sales and related SEC regulations.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.